François Lebreton1,2, Michael D Valentino1,2, Katharina Schaufler1,2, Ashlee M Earl2, Vincent Cattoir3,4, Michael S Gilmore1,2. 1. Departments of Ophthalmology, Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA. 2. Infectious Disease & Microbiome Program, The Broad Institute, Cambridge, MA, USA. 3. Université de Caen Basse-Normandie, EA4655 U2RM (équipe 'Antibio-résistance'), Caen, France. 4. CHU de Caen, Service de Microbiologie, Caen, France.
Abstract
Objectives: Vancomycin-resistant Enterococcus faecium is a leading cause of MDR hospital infection. Two genetically definable populations of E. faecium have been identified: hospital-adapted MDR isolates (clade A) and vancomycin-susceptible commensal strains (clade B). VanN-type vancomycin resistance was identified in two isolates of E. faecium recovered from blood and faeces of an immunocompromised patient. To understand the genomic context in which VanN occurred in the hospitalized patient, the risk it posed for transmission in the hospital and its origins, it was of interest to determine where these strains placed within the E. faecium population structure. Methods: We obtained the genome sequence of the VanN isolates and performed comparative and functional genomics of the chromosome and plasmid content. Results: We show that, in these strains, VanN occurs in a genetic background that clusters with clade B E. faecium, which is highly unusual. We characterized the chromosome and the conjugative plasmid that carries VanN resistance in these strains, pUV24. This plasmid exhibits signatures of in-host selection on the vanN operon regulatory system, which are associated with a constitutive expression of vancomycin resistance. VanN resistance in clade B strains may go undetected by current methods. Conclusions: We report a case of vancomycin resistance in a commensal lineage of E. faecium responsible for an atypical bacteraemia in an immunocompromised patient. A reservoir of transferable glycopeptide resistance in the community could pose a concern for public health.
Objectives:Vancomycin-resistant Enterococcus faecium is a leading cause of MDR hospital infection. Two genetically definable populations of E. faecium have been identified: hospital-adapted MDR isolates (clade A) and vancomycin-susceptible commensal strains (clade B). VanN-type vancomycin resistance was identified in two isolates of E. faecium recovered from blood and faeces of an immunocompromised patient. To understand the genomic context in which VanN occurred in the hospitalized patient, the risk it posed for transmission in the hospital and its origins, it was of interest to determine where these strains placed within the E. faecium population structure. Methods: We obtained the genome sequence of the VanN isolates and performed comparative and functional genomics of the chromosome and plasmid content. Results: We show that, in these strains, VanN occurs in a genetic background that clusters with clade B E. faecium, which is highly unusual. We characterized the chromosome and the conjugative plasmid that carries VanN resistance in these strains, pUV24. This plasmid exhibits signatures of in-host selection on the vanN operon regulatory system, which are associated with a constitutive expression of vancomycin resistance. VanN resistance in clade B strains may go undetected by current methods. Conclusions: We report a case of vancomycin resistance in a commensal lineage of E. faecium responsible for an atypical bacteraemia in an immunocompromised patient. A reservoir of transferable glycopeptide resistance in the community could pose a concern for public health.
Authors: William Brockman; Pablo Alvarez; Sarah Young; Manuel Garber; Georgia Giannoukos; William L Lee; Carsten Russ; Eric S Lander; Chad Nusbaum; David B Jaffe Journal: Genome Res Date: 2008-01-22 Impact factor: 9.043
Authors: Willem van Schaik; Janetta Top; David R Riley; Jos Boekhorst; Joyce E P Vrijenhoek; Claudia M E Schapendonk; Antoni P A Hendrickx; Isaäc J Nijman; Marc J M Bonten; Hervé Tettelin; Rob J L Willems Journal: BMC Genomics Date: 2010-04-14 Impact factor: 3.969
Authors: Malgorzata Mikulska; Valerio Del Bono; Anna Maria Raiola; Barbara Bruno; Francesca Gualandi; Domenico Occhini; Carmen di Grazia; Francesco Frassoni; Andrea Bacigalupo; Claudio Viscoli Journal: Biol Blood Marrow Transplant Date: 2009-01 Impact factor: 5.742
Authors: Kelli L Palmer; Paul Godfrey; Allison Griggs; Veronica N Kos; Jeremy Zucker; Christopher Desjardins; Gustavo Cerqueira; Dirk Gevers; Suzanne Walker; Jennifer Wortman; Michael Feldgarden; Brian Haas; Bruce Birren; Michael S Gilmore Journal: MBio Date: 2012-03-01 Impact factor: 7.867
Authors: François Lebreton; Willem van Schaik; Abigail Manson McGuire; Paul Godfrey; Allison Griggs; Varun Mazumdar; Jukka Corander; Lu Cheng; Sakina Saif; Sarah Young; Qiandong Zeng; Jennifer Wortman; Bruce Birren; Rob J L Willems; Ashlee M Earl; Michael S Gilmore Journal: mBio Date: 2013-08-20 Impact factor: 7.867
Authors: Alexey V Revtovich; Elissa Tjahjono; Kavindra V Singh; Blake M Hanson; Barbara E Murray; Natalia V Kirienko Journal: Front Cell Infect Microbiol Date: 2021-04-29 Impact factor: 5.293
Authors: Gustavo Henrique Rodrigues Vale de Macedo; Gabrielle Damasceno Evangelista Costa; Elane Rodrigues Oliveira; Glauciane Viera Damasceno; Juliana Silva Pereira Mendonça; Lucas Dos Santos Silva; Vitor Lopes Chagas; José Manuel Noguera Bazán; Amanda Silva Dos Santos Aliança; Rita de Cássia Mendonça de Miranda; Adrielle Zagmignan; Andrea de Souza Monteiro; Luís Cláudio Nascimento da Silva Journal: Pathogens Date: 2021-02-02
Authors: András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai Journal: Pathogens Date: 2020-06-29